Related Experiment Video

Updated: Jun 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Diagnosis and treatment of scleritis associated to inflammatory systemic diseases]

C Tappeiner1, A Heiligenhaus

  • 1Universitätsklinik für Augenheilkunde, Inselspital, Universität Bern. christoph.tappeiner@insel.ch

Klinische Monatsblatter Fur Augenheilkunde
|May 3, 2011
PubMed

Insights

Scleritis management requires prompt diagnosis and aggressive anti-inflammatory treatment to prevent vision loss and associated systemic disease mortality. Novel therapies, including biologics, offer new hope for difficult-to-treat scleritis cases.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Context:

  • Scleritis, an inflammation of the eye's white outer layer, poses risks of vision loss.
  • It is frequently linked to systemic inflammatory conditions, increasing patient mortality.
  • Effective management necessitates comprehensive diagnostic evaluation.

Purpose:

  • To underscore the critical need for timely and thorough diagnostic work-ups in scleritis patients.
  • To emphasize the importance of early and aggressive systemic anti-inflammatory treatment.
  • To highlight advancements in therapeutic options for refractory cases.

Summary:

  • Scleritis management demands a dual approach: accurate diagnosis and potent anti-inflammatory systemic therapies.
  • Aggressive treatment is crucial to mitigate vision-threatening complications and reduce mortality associated with systemic inflammatory diseases.
  • Emerging treatments, such as biological agents, are proving effective in achieving remission in patients with resistant scleritis.

Impact:

  • Improved patient outcomes through early intervention and tailored treatment strategies.
  • Reduced morbidity and mortality by addressing both ocular and systemic manifestations of scleritis.
  • Expanded therapeutic armamentarium for ophthalmologists and rheumatologists managing complex scleritis cases.

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...